New data demonstrated that long-acting cabotegravir was preferable to daily dolutegravir/lamivudine in treatment-naive people living with HIV.

Researchers have developed a powerful new tool that makes it easier to study the mix of cell types in human tissue, which is ...

As per projections, the hematology analyzers market size is expected to witness substantial growth in the coming years, reaching a whopping $5.3 billion in 2029 with a steady CAGR of 6.9%.

As per projections, the hematology analyzers market size is expected to witness substantial growth in the coming years, reaching a whopping $5.3 billion in 2029 with a steady CAGR of 6.9%.

A grassroots organization that formed with the goal of recalibrating cancer care around patient needs issued guidance intended to improve the design of randomized phase 3 trials.The goal is to ...

They investigated the correlation between neutrophil percentages from automated hematology analyzers and manual microscopic examinations on the first day of chemotherapy in 125 patients receiving CHOP ...

Sysmex America’s XQ-320 to be Distributed in U.S., Canada and Brazil CHICAGO, March 3, 2025 /CNW/ — Sysmex America, Inc., a leading diagnostic solutions company offering hematology, hemostasis, ...

For physician office laboratories, stat labs, or wherever rapid response diagnostic testing is required, the XQ-320 is the first 3-part differential analyzer with BeyondCare℠ Quality Monitor*.

CHICAGO, March 3, 2025 /CNW/ -- Sysmex America, Inc., a leading diagnostic solutions company offering hematology, hemostasis, urinalysis, flow cytometry and informatic solutions, today announced the ...